| Ticker Details |
Array Technologies, Inc.
Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
|
| IPO Date: |
October 15, 2020 |
| Sector: |
Technology |
| Industry: |
Solar |
| Market Cap: |
$1.72B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.51 | 3.32%
|
| Avg Daily Range (30 D): |
$0.39 | 3.68%
|
| Avg Daily Range (90 D): |
$0.36 | 3.84%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.48M |
| Avg Daily Volume (30 D): |
4.89M |
| Avg Daily Volume (90 D): |
5.35M |
| Trade Size |
| Avg Trade Size (Sh.): |
123 |
| Avg Trade Size (Sh.) (30 D): |
109 |
| Avg Trade Size (Sh.) (90 D): |
127 |
| Institutional Trades |
| Total Institutional Trades: |
6,279 |
| Avg Institutional Trade: |
$2.31M |
| Avg Institutional Trade (30 D): |
$2.66M |
| Avg Institutional Trade (90 D): |
$2.78M |
| Avg Institutional Trade Volume: |
.17M |
| Avg Institutional Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.03M |
| Avg Closing Trade (30 D): |
$4.95M |
| Avg Closing Trade (90 D): |
$4.85M |
| Avg Closing Volume: |
371.69K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$.12
|
$.19
|
|
Diluted EPS
|
|
$.12
|
$.19
|
|
Revenue
|
|
$393.49M
|
$362.24M
|
|
Gross Profit
|
|
$105.67M
|
$97.12M
|
|
Net Income / Loss
|
|
$33.5M
|
$43.26M
|
|
Operating Income / Loss
|
|
$45.45M
|
$46.38M
|
|
Cost of Revenue
|
|
$287.82M
|
$265.12M
|
|
Net Cash Flow
|
|
$-155.67M
|
$29.28M
|
|
PE Ratio
|
|
|
|
|
|
|
